Literature DB >> 24301421

Asymmetric dimethylarginine and augmentation index in newly diagnosed patients with hypertension.

Mustafa Cakar1, Fatih Bulucu1, Murat Karaman1, Seyit Ahmet Ay1, Ömer Kurt1, Şevket Balta2, Sait Demirkol3, Hakan Sarlak1, Muharrem Akhan1, Battal Altun4, Halil Yaman5, Erol Arslan1, Şeref Demirbaş1, Kenan Sağlam1.   

Abstract

Pulse wave velocity (PWV), augmentation index (Aix), and central aortic pressure (CAP) are arterial stiffness markers of endothelial dysfunction (ED). We investigated the relationship between arterial stiffness parameters and asymmetric dimethylarginine (ADMA; a marker of ED), in newly diagnosed patients with hypertension (n = 101; 61 females). These patients were investigated in accordance with the recommendations of hypertension guidelines. Arterial stiffness was measured, and serum ADMA and C-reactive protein (CRP; a marker of inflammation) levels were determined. In both women and men, there was no difference in terms of age, body mass index, systolic and diastolic blood pressures, PWV, CAP and the levels of ADMA, while Aix and CRP levels were significantly higher in women (P = .004, P = .046, respectively). In the whole group, ADMA levels correlated with Aix (Pearson r = .237, P = .024). Our findings provide further evidence of a link between arterial stiffness and ED in newly diagnosed patients with hypertension.
© The Author(s) 2013.

Entities:  

Keywords:  ADMA; CRP; arterial stiffness; augmentation index; central aortic pressure; pulse wave velocity

Mesh:

Substances:

Year:  2013        PMID: 24301421     DOI: 10.1177/0003319713513145

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  6 in total

Review 1.  Clinical Significance of Endothelial Dysfunction in Essential Hypertension.

Authors:  Eugenia Gkaliagkousi; Eleni Gavriilaki; Areti Triantafyllou; Stella Douma
Journal:  Curr Hypertens Rep       Date:  2015-11       Impact factor: 5.369

2.  Angiotensin-converting Enzyme Inhibition Improves the Effectiveness of Transcutaneous Carbon Dioxide Treatment.

Authors:  Balazs Nemeth; Istvan Kiss; Timea Jencsik; Ivan Peter; Zita Kreska; Tamas Koszegi; Attila Miseta; Peter Kustan; Imre Boncz; Andrea Laczo; Zeno Ajtay
Journal:  In Vivo       Date:  2017 May-Jun       Impact factor: 2.155

3.  Age and gender differences in the influences of eNOS T-786C polymorphism on arteriosclerotic parameters in general population in Japan.

Authors:  Marowa Hashimoto; Nobuyuki Miyai; Sonomi Hattori; Akihiko Iwahara; Miyoko Utsumi; Mikio Arita; Tatsuya Takeshita
Journal:  Environ Health Prev Med       Date:  2016-04-01       Impact factor: 3.674

4.  Investigation of the arterial stiffness and associated factors in patients with familial Mediterranean fever.

Authors:  Mustafa Çakar; Muharrem Akhan; Tolga Doğan; Gürhan Taşkın; Kadir Öztürk; Muhammet Çınar; Erol Arslan; Sedat Yılmaz
Journal:  Anatol J Cardiol       Date:  2016-07-21       Impact factor: 1.596

5.  Asymmetric dimethylarginine levels are associated with augmentation index across naïve untreated patients with different hypertension phenotypes.

Authors:  Eugenia Gkaliagkousi; Eleni Gavriilaki; Areti Triantafyllou; Barbara Nikolaidou; Panagiota Anyfanti; Nikolaos Koletsos; Anastasios Vamvakis; Konstantina Dipla; Antonios Lazaridis; Stella Douma
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-02-15       Impact factor: 3.738

6.  Multidisciplinary Treatment of the Metabolic Syndrome Lowers Blood Pressure Variability Independent of Blood Pressure Control.

Authors:  Yonit Marcus; Elad Segev; Gabi Shefer; Jessica Sack; Brurya Tal; Marianna Yaron; Eli Carmeli; Lili Shefer; Miri Margaliot; Rona Limor; Suzan Gilad; Yael Sofer; Naftali Stern
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-09-26       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.